Test ID: CA153
Cancer Antigen 15-3 (CA 15-3), Serum
NY State Approved 
Indicates the status of NY State approval and if the test is orderable for NY State clients.
Yes
Useful For Suggests clinical disorders or settings where the test may be helpful
The management of breast cancer patients when used in conjunction with clinical information and other diagnostic procedures. Serial testing can assist in early detection of disease recurrence in previously treated stage II and III breast cancer patients
Monitoring response to therapy in metastatic breast cancer patients
Method Name A short description of the method used to perform the test
Electrochemiluminescence Immunoassay
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
Cancer Ag 15-3, (CA 15-3), S
Aliases Lists additional common names for a test, as an aid in searching
CA 15-3 (Cancer Antigen 15-3)
CA153
MUC-1
Mucin-Like Carcinoma-Associated Antigen
CA153
MUC-1
Mucin-Like Carcinoma-Associated Antigen
External
link
PDF
document
Excel
document
Word
document